What causes gingivitis: plaque biofilm is the universal trigger
What causes gingivitis in humans? The answer is consistent across every systematic review published in the past decade: dental plaque biofilm. Gingivitis is the body’s inflammatory response to bacterial accumulation at the gum line. Without plaque, gingivitis does not occur. With plaque, gingivitis appears in every person within 10 to 21 days.12
Plaque biofilm is a structured microbial community, not a random collection of bacteria. It adheres to tooth surfaces and the gingival margin, creating a protected environment where bacteria metabolize nutrients, produce acids, and trigger immune responses. The biofilm contains hundreds of bacterial species, but the transition from health to gingivitis is driven by shifts in microbial composition and metabolic activity.45
Early-stage biofilm is dominated by gram-positive aerobic species. As the biofilm matures and thickens, anaerobic gram-negative species increase in proportion. These anaerobic bacteria produce proteolytic enzymes and endotoxins (lipopolysaccharides) that penetrate gingival tissue and activate the host immune response.67
The inflammatory response follows within days. Gingival blood flow increases, capillaries dilate, and immune cells (neutrophils, macrophages, lymphocytes) migrate to the gingival sulcus. Clinically, this appears as redness, swelling, and bleeding on gentle probing. Bleeding gums causes are therefore not mysterious: they are the visible result of vascular permeability and immune cell infiltration triggered by bacterial endotoxins.2
Plaque biofilm triggers gingivitis in everyone exposed, but severity and chronicity are determined by host factors: diabetes, hormonal fluctuations, medications, and genetic predisposition.
How the biofilm-inflammation cycle works
The progression from plaque accumulation to clinical gingivitis follows a predictable sequence. Bacterial colonization begins within hours of tooth cleaning. Early colonizers (primarily Streptococcus and Actinomyces species) attach to the acquired pellicle, a protein film that forms on tooth surfaces within minutes of cleaning.4
Within 24 to 48 hours, secondary colonizers join the biofilm. These include Fusobacterium nucleatum, which acts as a bridge species, binding both to early colonizers and to late-colonizing pathogenic species. By day 7 to 10, the biofilm has stratified into layers, with anaerobic species dominating the deeper portions adjacent to gingival tissue.6
Bacterial metabolism within the biofilm produces metabolic byproducts that are directly toxic to host tissue. Proteolytic enzymes degrade collagen and extracellular matrix proteins. Short-chain fatty acids (butyrate, propionate) inhibit epithelial cell proliferation and induce apoptosis. Lipopolysaccharides from gram-negative bacteria bind to toll-like receptors on immune cells, triggering the release of pro-inflammatory cytokines.58
The host response amplifies the inflammatory cascade. Interleukin-1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6) are released by macrophages and gingival fibroblasts. These cytokines recruit neutrophils to the site, increase vascular permeability, and upregulate matrix metalloproteinases that degrade connective tissue.910
In gingivitis, this inflammatory response remains confined to the gingival tissue. The junctional epithelium (the seal between tooth and gum) remains intact, and there is no loss of connective tissue attachment or alveolar bone. This distinguishes gingivitis from periodontitis, where the inflammatory response extends apically and destroys the periodontal ligament.2
Critically, the inflammatory response is reversible. When plaque is removed and biofilm disruption is maintained through mechanical cleaning, the inflammatory infiltrate resolves within 7 to 14 days, and gingival tissues return to clinical health.12
What causes gingivitis to become severe or chronic
Plaque biofilm is the necessary cause, but it is not sufficient to explain the wide variation in gingivitis severity observed in clinical populations. Two people with similar plaque levels may show markedly different inflammatory responses. The difference lies in host susceptibility, which is modulated by systemic, hormonal, genetic, and pharmacological factors.3
Diabetes is the most thoroughly documented systemic risk factor. Children and adolescents with type 1 diabetes show significantly higher gingival inflammation and bleeding on probing compared to non-diabetic controls, even when plaque levels are comparable.1113 The relationship is bidirectional: hyperglycemia impairs neutrophil function, reduces collagen synthesis, and increases production of advanced glycation end products (AGEs) that sustain chronic inflammation. Conversely, periodontal inflammation worsens insulin resistance and glycemic control.12
Hormonal fluctuations increase gingival sensitivity to plaque. Pregnancy, puberty, and the menstrual cycle all elevate levels of estrogen and progesterone, which increase gingival vascular permeability and alter the composition of subgingival microbiota. During pregnancy, Prevotella intermedia increases in proportion, and gingival inflammation often appears disproportionate to plaque levels.14
Medications modify gingival tissue response. Three drug classes are implicated: anticonvulsants (phenytoin), calcium channel blockers (nifedipine, amlodipine), and immunosuppressants (cyclosporine). These drugs induce gingival overgrowth, a condition distinct from but often accompanied by inflammation. The overgrown tissue traps plaque and exacerbates inflammatory responses.15
Genetic predisposition accounts for a measurable proportion of variability. Twin studies and family aggregation studies estimate that 30 to 50 percent of periodontal disease susceptibility is heritable. Polymorphisms in genes encoding IL-1, IL-6, and TNF-α influence the magnitude of the inflammatory response to bacterial challenge.16
Psychological stress and behavioral factors also contribute. Adolescents with anxiety or depression show higher rates of gingivitis, likely mediated by stress-induced immune dysregulation and reduced adherence to oral hygiene.17
| Risk factor | Mechanism | Relative effect size |
|---|---|---|
| Diabetes (type 1 or 2) | Impaired neutrophil function, hyperglycemia, AGE accumulation | 2 to 3 times higher gingival inflammation |
| Pregnancy | Elevated estrogen/progesterone, altered microbiome | 40 to 70 percent prevalence of pregnancy gingivitis |
| Medications (phenytoin, cyclosporine, CCBs) | Gingival overgrowth, plaque retention | 10 to 50 percent of users develop overgrowth |
| Genetic predisposition | Polymorphisms in IL-1, IL-6, TNF-α genes | 30 to 50 percent heritability estimate |
| Psychological stress | Immune dysregulation, reduced hygiene adherence | Modest increase, mediated by behavior |
Host factors that amplify gingival inflammatory response to plaque biofilm
How long gingivitis lasts when treated vs. untreated
How long does gingivitis last? The answer depends entirely on whether plaque biofilm is disrupted. With mechanical plaque removal (toothbrushing, flossing, professional cleaning), clinical signs of gingivitis resolve within 7 to 14 days.2
Experimental gingivitis studies provide the clearest evidence. When healthy volunteers stop all oral hygiene, gingivitis develops within 10 to 21 days. When they resume brushing and flossing, gingival inflammation returns to baseline within 1 to 2 weeks. This reversibility has been confirmed in dozens of controlled trials.12
Professional scaling and root planing accelerate resolution, particularly when supragingival and subgingival calculus (mineralized plaque) is present. Calculus acts as a reservoir for bacterial recolonization and prevents effective self-care. Mechanical removal of calculus combined with improved home care produces resolution in 1 to 2 weeks.2
Without treatment, gingivitis persists indefinitely. Chronic gingivitis is characterized by sustained low-grade inflammation with periodic exacerbations. The inflammation does not resolve spontaneously, because the biofilm is not disrupted. In a subset of individuals (estimated at 10 to 15 percent), untreated gingivitis progresses to periodontitis, where attachment loss and bone destruction occur.2
The transition from gingivitis to periodontitis is not inevitable. Most gingivitis sites remain stable for years without progressing. The factors that determine which sites progress are incompletely understood but include the presence of specific pathogenic species (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola), host genetic susceptibility, and systemic modifiers such as smoking and diabetes.37
How to prevent gingivitis: evidence-based strategies
Prevention requires sustained disruption of plaque biofilm. The evidence base for preventive strategies is large and consistent. Mechanical plaque removal is the cornerstone. Toothbrushing twice daily with a soft-bristled brush reduces gingivitis by 40 to 60 percent in controlled trials.2
Interdental cleaning (flossing, interdental brushes, water flossers) addresses areas that toothbrushes cannot reach. The proximal surfaces between teeth and the gingival sulcus harbor the majority of plaque in most individuals. Daily interdental cleaning reduces interproximal gingivitis by 30 to 50 percent compared to brushing alone.2
Antimicrobial mouth rinses provide adjunctive benefit. Chlorhexidine gluconate (0.12 percent or 0.2 percent) is the most extensively studied agent. It binds to oral tissues and provides sustained antibacterial activity for 8 to 12 hours. When used twice daily as an adjunct to mechanical cleaning, chlorhexidine reduces gingivitis by an additional 20 to 30 percent.2
Essential oil mouth rinses (containing menthol, thymol, eucalyptol, and methyl salicylate) also reduce plaque and gingivitis, with effect sizes roughly half that of chlorhexidine. Cetylpyridinium chloride rinses show modest benefit. The evidence for hydrogen peroxide rinses is weaker.2
Professional maintenance is necessary for individuals with calculus formation or difficult-to-reach areas. Scaling and polishing every 3 to 6 months prevents accumulation of mineralized deposits and provides an opportunity to reinforce self-care technique.2
Systemic management is critical for individuals with diabetes, hormonal changes, or medication-induced gingival overgrowth. Glycemic control reduces periodontal inflammation in diabetic patients. Substitution or dose adjustment of gingival-overgrowth-inducing medications (when medically feasible) improves outcomes.1215
Gingivitis is reversible, but only if plaque biofilm is disrupted. Bleeding on brushing or flossing is the earliest clinical sign. It indicates that inflammation is already present. Waiting for pain or swelling means the condition has advanced. Daily mechanical plaque removal, combined with professional cleaning every 3 to 6 months, prevents gingivitis in the majority of individuals.
Sources
- Tsilingaridis G, et al. Dental Biofilm-Induced Gingivitis in Children and Adolescents Without Known Systemic Involvement: A Systematic Review. J Clin Periodontol, 2026. PubMed
- Chapple IL, et al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol, 2015. PubMed
- Chapple IL, et al. Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol, 2017. PubMed
- Marsh PD. In Sickness and in Health-What Does the Oral Microbiome Mean to Us? An Ecological Perspective. Adv Dent Res, 2018. PubMed
- Takahashi N. Oral Microbiome Metabolism: From "Who Are They?" to "What Are They Doing?". J Dent Res, 2015. PubMed
- Diaz PI. Microbial diversity and interactions in subgingival biofilm communities. Front Oral Biol, 2012. PubMed
- Bostanci N, et al. Microbial Markers for Diagnosis and Risk Assessment for Periodontal Diseases: A Systematic Literature Search and Narrative Synthesis. J Clin Periodontol, 2025. PubMed
- Phanrungsuwan A, et al. Host modulation therapy in periodontitis: from established therapies to emerging technologies. Front Immunol, 2026. PubMed
- Ademi A, et al. Oral Barrier Immunometabolism in Chronic Low-Grade Inflammation: Molecular Mechanisms and Systemic Implications. Int J Mol Sci, 2026. PubMed
- Salgado-Martínez Y, et al. [Interleukins involved in bone degeneration from periodontal disease: Systematic review]. Rev Med Inst Mex Seguro Soc, 2025. PubMed
- Jensen E, et al. Periodontal risk markers in children and adolescents with type 1 diabetes: A systematic review and meta-analysis. Diabetes Metab Res Rev, 2021. PubMed
- Simpson TC, et al. Treatment of periodontitis for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev, 2022. PubMed
- Pappa A, et al. Dental caries and periodontal status in children and adolescents with type 1 diabetes mellitus: an umbrella review. Eur Arch Paediatr Dent, 2026. PubMed
- Jawed STM, Tul Kubra Jawed K. Understanding the Link Between Hormonal Changes and Gingival Health in Women: A Review. Cureus, 2025. PubMed
- Hu J, et al. Non-surgical treatment of cyclosporin A-induced gingival overgrowth: A systematic review and meta-analysis. Medicine (Baltimore), 2025. PubMed
- Nibali L, et al. What Is the Heritability of Periodontitis? A Systematic Review. J Dent Res, 2019. PubMed
- Alagarda-Lauwers B, et al. Psychological disorders and their influence on the development of periodontal disease in adolescents. A systematic review. Med Oral Patol Oral Cir Bucal, 2026. PubMed